Medical economics

COVID-19: Governments must stop vaccine cost secrecy

Globally affordable COVID-19 vaccines will not be accessible until governments stop allowing vaccine companies to keep their manufacturing costs secret, according to a new paper published by the Journal of the Royal Society ...

Vaccination

FDA advisers weigh COVID-19 booster shots for fall

Outlining a daunting timeline for development of any updated COVID-19 vaccine for next fall, federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin ...

Vaccination

Expert discusses rapid mRNA vaccine production

The COVID-19 pandemic has resulted in the successful advancement of mRNA vaccine technology. This has however left many people wondering how it is mRNA vaccines were developed so quickly. Bill Anderson, professor emeritus ...

Vaccination

US-Germany rift could scupper vaccine patent waiver

A bold US bid to waive patents on much-needed coronavirus vaccines was strongly opposed by Germany on Thursday, threatening to derail the proposal that requires the consensus of World Trade Organization members to pass.

Vaccination

Canada reaches deal with Pfizer for vaccines in future years

Prime Minister Justin Trudeau said Friday Canada has reached an agreement with Pfizer for 35 million booster shots next year and 30 million in 2023 in case the effectiveness of COVID-19 vaccines fades with time and need to ...

Vaccination

Oxford vaccine reaches 2-billion-dose milestone

Today, as AstraZeneca reports 2 billion doses of the COVID-19 vaccine released for supply, University of Oxford scientists explain how it has been possible to produce so much of the vaccine in less than a year, and the unprecedented ...

page 3 from 8